Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in Acta Neurol Scand

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ELKJAER ML, Molnar T, Illes Z
    Teriflunomide for multiple sclerosis in real-world setting.
    Acta Neurol Scand. 2017 Mar 20. doi: 10.1111/ane.12755.
    PubMed     Text format     Abstract available


  2. SCHNEIDER R, Bellenberg B, Kleiter I, Gold R, et al
    Cervical cord and ventricle affection in neuromyelitis optica.
    Acta Neurol Scand. 2017;135:324-331.
    PubMed     Text format     Abstract available


    February 2017
  3. ENSARI I, Pilutti LA, Motl RW
    Depressive symptomology in multiple sclerosis: Disability, cardiorespiratory fitness and heart rate variability.
    Acta Neurol Scand. 2017 Feb 26. doi: 10.1111/ane.12748.
    PubMed     Text format     Abstract available


    January 2017
  4. LUNDELL H, Svolgaard O, Dogonowski AM, Romme Christensen J, et al
    Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Acta Neurol Scand. 2017 Jan 10. doi: 10.1111/ane.12729.
    PubMed     Text format     Abstract available


  5. VOLDSGAARD A, Koch-Henriksen N, Magyari M, Sellebjerg F, et al
    Early safety and efficacy of fingolimod treatment in Denmark.
    Acta Neurol Scand. 2017;135:129-133.
    PubMed     Text format     Abstract available


    December 2016
  6. KARAMYAN A, Brandtner H, Grinzinger S, Chroust V, et al
    Causes of death in critically ill multiple sclerosis patients.
    Acta Neurol Scand. 2016 Dec 23. doi: 10.1111/ane.12724.
    PubMed     Text format     Abstract available


  7. TANASESCU R, Midgley A, Robins RA, Constantinescu CS, et al
    Decreased interferon-beta induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.
    Acta Neurol Scand. 2016 Dec 5. doi: 10.1111/ane.12715.
    PubMed     Text format     Abstract available


  8. D'HOOGHE MB, Haentjens P, Van Remoortel A, De Keyser J, et al
    Self-reported levels of education and disability progression in multiple sclerosis.
    Acta Neurol Scand. 2016;134:414-419.
    PubMed     Text format     Abstract available


    November 2016
  9. PEARSON JF, Alla S, Clarke G, Mason DF, et al
    Multiple Sclerosis impact on employment and income in New Zealand.
    Acta Neurol Scand. 2016 Nov 28. doi: 10.1111/ane.12714.
    PubMed     Text format     Abstract available


  10. SOELBERG SORENSEN P
    Safety concerns and risk management of multiple sclerosis therapies.
    Acta Neurol Scand. 2016 Nov 27. doi: 10.1111/ane.12712.
    PubMed     Text format     Abstract available


    October 2016
  11. ZETTL UK, Schreiber H, Bauer-Steinhusen U, Glaser T, et al
    Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis.
    Acta Neurol Scand. 2016 Oct 30. doi: 10.1111/ane.12705.
    PubMed     Text format     Abstract available


  12. GOUVEIA A, Dias SP, Santos T, Rocha H, et al
    Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis.
    Acta Neurol Scand. 2016 Oct 24. doi: 10.1111/ane.12702.
    PubMed     Text format     Abstract available


  13. ETEMADIFAR M, Mehrabi B, Kiani-Peykani R, Abtahi SH, et al
    Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran.
    Acta Neurol Scand. 2016;134:292-9.
    PubMed     Text format     Abstract available


    September 2016
  14. PUZ P, Lasek-Bal A, Radecka P
    Transcranial sonography of subcortical structures in patients with multiple sclerosis.
    Acta Neurol Scand. 2016 Sep 18. doi: 10.1111/ane.12689.
    PubMed     Text format     Abstract available


  15. ROMMER PS, Suhnel A, Konig N, Zettl UK, et al
    Coping with multiple sclerosis-the role of social support.
    Acta Neurol Scand. 2016 Sep 12. doi: 10.1111/ane.12673.
    PubMed     Text format     Abstract available


  16. BRENNER P, Piehl F
    Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
    Acta Neurol Scand. 2016;134 Suppl 200:47-54.
    PubMed     Text format     Abstract available


  17. ROCCA MA, De Meo E, Filippi M
    Functional MRI in investigating cognitive impairment in multiple sclerosis.
    Acta Neurol Scand. 2016;134 Suppl 200:39-46.
    PubMed     Text format     Abstract available


  18. PENNER IK
    Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions.
    Acta Neurol Scand. 2016;134 Suppl 200:19-23.
    PubMed     Text format     Abstract available


  19. MUCKSCHEL M, Beste C, Ziemssen T
    Immunomodulatory treatments and cognition in MS.
    Acta Neurol Scand. 2016;134 Suppl 200:55-9.
    PubMed     Text format     Abstract available


  20. BERGER T
    Immunological processes related to cognitive impairment in MS.
    Acta Neurol Scand. 2016;134 Suppl 200:34-8.
    PubMed     Text format     Abstract available


  21. PAUL F
    Pathology and MRI: exploring cognitive impairment in MS.
    Acta Neurol Scand. 2016;134 Suppl 200:24-33.
    PubMed     Text format     Abstract available


  22. PORTACCIO E
    Differential diagnosis, discerning depression from cognition.
    Acta Neurol Scand. 2016;134 Suppl 200:14-8.
    PubMed     Text format     Abstract available


  23. HAMALAINEN P, Rosti-Otajarvi E
    Cognitive impairment in MS: rehabilitation approaches.
    Acta Neurol Scand. 2016;134 Suppl 200:8-13.
    PubMed     Text format     Abstract available


  24. VAN ETTINGER-VEENSTRA H
    Cumulative evidence for MS as a neural network disconnection syndrome consistent with cognitive impairment mechanisms and the confounding role of fatigue and depression-outlook from the Fourth Nordic MS symposium.
    Acta Neurol Scand. 2016;134 Suppl 200:4-7.
    PubMed     Text format     Abstract available


    August 2016
  25. VAGBERG M, Axelsson M, Birgander R, Burman J, et al
    Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society.
    Acta Neurol Scand. 2016 Aug 24. doi: 10.1111/ane.12667.
    PubMed     Text format     Abstract available


  26. CAROTENUTO A, Iodice R, Petracca M, Inglese M, et al
    Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(R).
    Acta Neurol Scand. 2016 Aug 8. doi: 10.1111/ane.12660.
    PubMed     Text format     Abstract available


    June 2016
  27. RONNING OM, Tornes KD
    Need for symptomatic management in advanced multiple sclerosis.
    Acta Neurol Scand. 2016 Jun 29. doi: 10.1111/ane.12631.
    PubMed     Text format     Abstract available


  28. MOCCIA M, Palladino R, Lanzillo R, Triassi M, et al
    Predictors of the 10-year direct costs for treating multiple sclerosis.
    Acta Neurol Scand. 2016 Jun 29. doi: 10.1111/ane.12630.
    PubMed     Text format     Abstract available


  29. AIVO J, Kurki S, Sumelahti ML, Hanninen K, et al
    Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland.
    Acta Neurol Scand. 2016 Jun 22. doi: 10.1111/ane.12623.
    PubMed     Text format     Abstract available


  30. SKIERLO S, Rommer PS, Zettl UK
    Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
    Acta Neurol Scand. 2016 Jun 9. doi: 10.1111/ane.12612.
    PubMed     Text format     Abstract available


    May 2016
  31. SIMONSEN CS, Edland A, Berg-Hansen P, Celius EG, et al
    High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud.
    Acta Neurol Scand. 2016 May 30. doi: 10.1111/ane.12615.
    PubMed     Text format     Abstract available


  32. KOLASA M, Hagman S, Verkkoniemi-Ahola A, Airas L, et al
    Anti-JC virus seroprevalence in a Finnish MS cohort.
    Acta Neurol Scand. 2016;133:391-7.
    PubMed     Text format     Abstract available


    April 2016
  33. HOLMOY T, Esbensen QY, Torkildsen O, Wergeland S, et al
    WT1 and interferon-beta-vitamin D association in MS: a longitudinal study.
    Acta Neurol Scand. 2016;133:309-12.
    PubMed     Text format     Abstract available


    February 2016
  34. SANTANGELO G, Sacco R, Siciliano M, Bisecco A, et al
    Anxiety in Multiple Sclerosis: psychometric properties of the State-Trait Anxiety Inventory.
    Acta Neurol Scand. 2016 Feb 1. doi: 10.1111/ane.12564.
    PubMed     Text format     Abstract available


    January 2016
  35. MILLER E, Kostka J, Wlodarczyk T, Dugue B, et al
    Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study.
    Acta Neurol Scand. 2016 Jan 18. doi: 10.1111/ane.12557.
    PubMed     Text format     Abstract available


    October 2015
  36. BERG-HANSEN P, Moen SM, Harbo HF, Celius EG, et al
    Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
    Acta Neurol Scand. 2015 Oct 1. doi: 10.1111/ane.12489.
    PubMed     Text format    


    September 2015
  37. CRISCUOLO C, Carbone R, Lieto M, Peluso S, et al
    SPG5 and multiple sclerosis: clinical and genetic overlap?
    Acta Neurol Scand. 2015 Sep 15. doi: 10.1111/ane.12476.
    PubMed     Text format     Abstract available


  38. GRYTTEN N, Torkildsen O, Myhr K
    Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
    Acta Neurol Scand. 2015 Sep 15. doi: 10.1111/ane.12488.
    PubMed     Text format    


    August 2015
  39. CATTANEO D, Carpinella I, Aprile I, Prosperini L, et al
    Comparison of upright balance in stroke, Parkinson and multiple sclerosis.
    Acta Neurol Scand. 2015 Aug 3. doi: 10.1111/ane.12466.
    PubMed     Text format     Abstract available


    July 2015
  40. WILSKI M, Tasiemski T
    Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis.
    Acta Neurol Scand. 2015 Jul 20. doi: 10.1111/ane.12465.
    PubMed     Text format     Abstract available


  41. YOKOTE H, Nose Y, Ishibashi S, Tanaka K, et al
    Spinal cord ring enhancement in patients with neuromyelitis optica.
    Acta Neurol Scand. 2015;132:37-41.
    PubMed     Text format     Abstract available


    June 2015
  42. DERETZI G, Gavalas E, Boziki M, Tsiptsios D, et al
    Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
    Acta Neurol Scand. 2015 Jun 16. doi: 10.1111/ane.12453.
    PubMed     Text format     Abstract available


    May 2015
  43. GAJOFATTO A, Turatti M, Bianchi MR, Forlivesi S, et al
    Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.
    Acta Neurol Scand. 2015 May 26. doi: 10.1111/ane.12442.
    PubMed     Text format     Abstract available


  44. HANSSEN KT, Beiske AG, Landro NI, Hofoss D, et al
    Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
    Acta Neurol Scand. 2015 May 8. doi: 10.1111/ane.12420.
    PubMed     Text format     Abstract available


  45. LATHAM LB, Lee MJ, Lincoln JA, Ji N, et al
    Antivirus immune activity in multiple sclerosis correlates with MRI activity.
    Acta Neurol Scand. 2015 May 4. doi: 10.1111/ane.12417.
    PubMed     Text format     Abstract available


  46. DE GIGLIO L, Gasperini C, Tortorella C, Trojano M, et al
    Natalizumab discontinuation and disease restart in pregnancy: a case series.
    Acta Neurol Scand. 2015;131:336-40.
    PubMed     Text format     Abstract available


    April 2015
  47. SIMPSON S JR, Mina S, Morris H, Mahendran S, et al
    The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011.
    Acta Neurol Scand. 2015 Apr 20. doi: 10.1111/ane.12405.
    PubMed     Text format     Abstract available


  48. SVENNINGSSON A, Salzer J, Vagberg M, Sundstrom P, et al
    Increasing prevalence of multiple sclerosis in Vasterbotten County of Sweden.
    Acta Neurol Scand. 2015 Apr 10. doi: 10.1111/ane.12408.
    PubMed     Text format     Abstract available


  49. LIN R, Taylor BV, Charlesworth J, van der Mei I, et al
    Modulating effects of WT1 on interferon-beta-vitamin D association in MS.
    Acta Neurol Scand. 2015;131:231-9.
    PubMed     Text format     Abstract available


    February 2015
  50. RAGGI A, Giovannetti AM, Schiavolin S, Confalonieri P, et al
    Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
    Acta Neurol Scand. 2015 Feb 18. doi: 10.1111/ane.12387.
    PubMed     Text format     Abstract available


  51. BOSNES O, Dahl OP, Almkvist O
    Including a subject-paced trial may make the PASAT more acceptable for MS patients.
    Acta Neurol Scand. 2015 Feb 18. doi: 10.1111/ane.12385.
    PubMed     Text format     Abstract available


  52. CEREZO GARCIA M, Martin Plasencia P, Aladro Benito Y
    Alteration profile of executive functions in multiple sclerosis.
    Acta Neurol Scand. 2015 Feb 8. doi: 10.1111/ane.12345.
    PubMed     Text format     Abstract available


  53. IZQUIERDO G, Venegas A, Sanabria C, Navarro G, et al
    Long-term epidemiology of multiple sclerosis in the Northern Seville District.
    Acta Neurol Scand. 2015 Feb 4. doi: 10.1111/ane.12363.
    PubMed     Text format     Abstract available


  54. FERNANDEZ-MUNOZ JJ, Moron-Verdasco A, Cigaran-Mendez M, Munoz-Hellin E, et al
    Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis.
    Acta Neurol Scand. 2015 Feb 3. doi: 10.1111/ane.12370.
    PubMed     Text format     Abstract available


  55. SIGNORIELLO E, Sagliocchi A, Fratta M, Lus G, et al
    Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
    Acta Neurol Scand. 2015;131:140-3.
    PubMed     Text format     Abstract available


    January 2015
  56. MOTL RW, McAuley E, Sandroff BM, Hubbard EA, et al
    Descriptive epidemiology of physical activity rates in multiple sclerosis.
    Acta Neurol Scand. 2015 Jan 18. doi: 10.1111/ane.12352.
    PubMed     Text format     Abstract available


  57. FREIDEL M, Tiel-Wilck K, Schreiber H, Prechtl A, et al
    Drug-resistant MS spasticity treatment with Sativex((R)) add-on and driving ability.
    Acta Neurol Scand. 2015;131:9-16.
    PubMed     Text format     Abstract available


  58. ANDERSEN O
    Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.
    Acta Neurol Scand. 2015;132:71-5.
    PubMed     Text format     Abstract available


  59. AIRAS L
    Hormonal and gender-related immune changes in multiple sclerosis.
    Acta Neurol Scand. 2015;132:62-70.
    PubMed     Text format     Abstract available


  60. SUNDSTROM P, Salzer J
    Vitamin D and multiple sclerosis-from epidemiology to prevention.
    Acta Neurol Scand. 2015;132:56-61.
    PubMed     Text format     Abstract available


  61. CORREALE J, Gaitan MI
    Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.
    Acta Neurol Scand. 2015;132:46-55.
    PubMed     Text format     Abstract available


  62. BOSTROM I, Landtblom AM
    Does the changing sex ratio of multiple sclerosis give opportunities for intervention?
    Acta Neurol Scand. 2015;132:42-5.
    PubMed     Text format     Abstract available


  63. BERG-HANSEN P, Celius EG
    Socio-economic factors and immigrant population studies of multiple sclerosis.
    Acta Neurol Scand. 2015;132:37-41.
    PubMed     Text format     Abstract available


  64. GRYTTEN N, Torkildsen O, Myhr KM
    Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
    Acta Neurol Scand. 2015;132:29-36.
    PubMed     Text format     Abstract available


  65. MYHR KM, Grytten N, Torkildsen O, Wergeland S, et al
    The Norwegian Multiple Sclerosis Registry and Biobank.
    Acta Neurol Scand. 2015;132:24-8.
    PubMed     Text format     Abstract available


  66. MAGYARI M
    Role of socio-economic and reproductive factors in the risk of multiple sclerosis.
    Acta Neurol Scand. 2015;132:20-3.
    PubMed     Text format     Abstract available


  67. HILLERT J, Stawiarz L
    The Swedish MS registry - clinical support tool and scientific resource.
    Acta Neurol Scand. 2015;132:11-9.
    PubMed     Text format     Abstract available


  68. KOCH-HENRIKSEN N, Magyari M, Laursen B
    Registers of multiple sclerosis in Denmark.
    Acta Neurol Scand. 2015;132:4-10.
    PubMed     Text format     Abstract available


  69. ANDERSEN O
    Nordic MS Epidemiology. Introduction.
    Acta Neurol Scand. 2015;132:1-3.
    PubMed     Text format    


    November 2014
  70. STICH O, Kluge J, Speck J, Rauer S, et al
    Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
    Acta Neurol Scand. 2014 Nov 17. doi: 10.1111/ane.12350.
    PubMed     Text format     Abstract available


    August 2014
  71. SALHOFER-POLANYI S, Baumgartner A, Kraus J, Maida E, et al
    What to expect after natalizumab cessation in a real-life setting.
    Acta Neurol Scand. 2014;130:97-102.
    PubMed     Text format     Abstract available


    June 2014
  72. FAGIUS J, Burman J
    Normal outcome of pregnancy with ongoing treatment with natalizumab.
    Acta Neurol Scand. 2014;129:e27-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: